Apical hypertrophic cardiomyopathy

Article written and reviewed by Dr Luca Moretti

Apical hypertrophic cardiomyopathy is a phenotype in which increased wall thickness predominantly involves the apex of the left ventricle. The distribution may be pure, confined to distal segments, or mixed, extending to mid or basal regions. The historical term Yamaguchi syndrome recalls the first Japanese descriptions, but the disease occurs in every population. Apical location modifies imaging sensitivity, cavity mechanics and the profile of complications.

The classic diagnosis used an apical thickness of at least 15 mm and an apical-to-basal wall thickness ratio greater than approximately 1.3. These thresholds identify overt forms but may miss relative apical hypertrophy, in which the apex is abnormally thick compared with the base despite not reaching 15 mm. Age, sex, body surface area and normal apical tapering must be considered. An absolute threshold does not replace assessment of geometry and electrical or tissue findings.

Echocardiography may fail to recognize the disease when the apex is off axis, foreshortened or obscured by artifacts. The cavity then appears normal or falsely obliterated and the measurement includes trabeculations rather than compact myocardium. Intracavitary contrast improves border definition, whereas CMR provides orthogonal planes and complete coverage. Missed diagnosis is particularly likely when the ECG shows deep T-wave inversions but the echocardiographic report is considered conclusive.

The spade-shaped appearance of the cavity in diastole is characteristic but not mandatory. Hypertrophy may obliterate the apex in systole, reduce effective volume and create an intracavitary gradient, particularly when it extends into the mid segments. Pressure, ischemia and scar may lead to an aneurysm, which is a thinned dyskinetic region distinct from simple cavity obliteration. Apical remodeling therefore describes a continuum among hypertrophy, a high-pressure chamber, scar and aneurysm.

Early series suggested an almost invariably benign prognosis, but larger cohorts have documented clinically meaningful events. Atrial fibrillation, heart failure, stroke, ventricular tachycardia and aneurysm affect recognizable subgroups. A recent contemporary study reported a composite event rate of approximately 2.8% per year in its cohort, demonstrating the need for dedicated stratification. Average prognosis therefore should not erase individual variability.

Definition, anatomic variants and etiology

In the pure form, hypertrophy predominates below the papillary muscles and the base retains relatively normal thickness. In the mixed form, the apex and other segments are involved and SAM or left ventricular outflow tract obstruction may coexist. The distinction is not merely descriptive because it changes volume, gradient and differential diagnosis. Segmental mapping reports maximal thickness, apex-to-base ratio and continuity of hypertrophy rather than applying a binary label.

Relative apical hypertrophy identifies an apex that does not show the normal progressive tapering and becomes thicker relative to the base while remaining below the conventional threshold. It may be associated with negative T waves, reduced cavity size, scar and family history. Not every relative variation represents disease, so pretest probability and associated findings are decisive. The early phenotype requires follow-up rather than immediately forcing a definitive diagnosis.

The frequency of the apical form ranges from a few percent in Western cohorts to higher proportions in some Asian series. Part of the difference reflects ancestry and part reflects criteria, selection and CMR availability. Increased sensitivity has reduced the simplistic opposition between Japanese and Western disease. Epidemiology should be interpreted by considering who underwent imaging and which relative forms were included.

Variants in sarcomeric genes may cause the phenotype, but genetic yield is often lower than in classic septal HCM and varies between pure and mixed forms. MYBPC3 and MYH7 remain common among resolved cases, without a one-to-one relationship between gene and distribution. A negative test does not prove a nongenetic cause. Family assessment therefore retains its value through ECG and imaging even when the panel identifies no variant.

Fabry disease may present with apical hypertrophy and should be considered especially in the presence of low native T1, neuropathic pain, angiokeratomas, cornea verticillata or renal involvement. Hypertension, athlete's heart and apical tumors or masses enter the differential diagnosis. Endomyocardial disease may obliterate the apex but has different tissue characteristics and history. Specific causes are named because some have etiologic therapy and different inheritance patterns.

The midventricular form may coexist with apical hypertrophy but is not synonymous with ApHCM. In midventricular narrowing, a distal chamber is separated from the base and exposed to high pressures; in pure apical disease, obliteration may occur without a true gradient between two chambers. Color Doppler and CMR localize the difference. The site of obstruction should be specified because it influences aneurysm risk and surgical options.

Papillary muscles may be hypertrophied and visually merge with the apex, causing overestimation of wall thickness. Abnormal insertions and cavity orientation influence flow and sometimes contribute to midventricular obstruction. Measurement should be performed on compact myocardium in correct planes. Papillary anatomy is also important if apical or midventricular myectomy is being considered.

The phenotype may evolve. A hypertrophied hyperkinetic apex may develop scar, thinning and aneurysm, whereas a relative form may become more evident with age. Progression is not inevitable and timing varies. Serial documentation of thickness, cavity, LGE and function makes it possible to distinguish a technical difference between examinations from true biological remodeling.

Age and sex influence the threshold at which a measurement appears abnormal. A 13-mm wall may represent an important relative increase in a small woman and a less specific finding in a large man. Anthropometric interpretation should accompany the apex-to-base ratio and history, especially in forms that do not reach the classic definition.

The diagnosis may emerge in relatives during screening, before symptoms or major T-wave inversions. At this stage, a minimal apical abnormality does not authorize predictions about future aneurysm. The subclinical phase requires reproducible measurements, counseling and proportionate intervals, avoiding medicalization of common anatomic variants without other supporting features.

Pathophysiology, obliteration and aneurysm

Hypertrophy reduces apical volume and may cause systolic contact between the walls, defined as obliteration. Global ejection fraction remains high because the base ejects a substantial proportion, but effective stroke volume may be limited. Apical strain is often reduced despite apparent hyperkinesis. The functional cavity is therefore smaller than the ejection percentage suggests.

When midventricular narrowing separates the apical chamber, distal pressure may rise markedly. The apex is exposed to systolic stress, unfavorable perfusion and ischemia, which promote transmural fibrosis and thinning. The process may resemble an infarction despite absence of corresponding epicardial coronary disease. A high-pressure apical chamber is an important mechanism, but aneurysms may also occur without an easily measurable midventricular gradient.

Apical perfusion is vulnerable because of greater myocardial mass, intramyocardial compression and microvascular disease. Tachycardia and high diastolic pressures further reduce the perfusion gradient. Chest pain and scar may therefore develop with normal epicardial coronary arteries. Chronic ischemia must nevertheless be distinguished from true coronary artery disease, especially in adults with risk factors.

An aneurysm is defined as a discrete, thinned, akinetic or dyskinetic apical segment, often with transmural LGE. Small aneurysms may be missed by noncontrast echocardiography and discovered by CMR. Size does not fully summarize risk because the scarred border can support arrhythmias. Identification of an aneurysm changes monitoring, ICD stratification and the search for thrombus.

Stasis within the aneurysmal cavity promotes mural thrombosis. A laminated thrombus may be mistaken for thickened endocardium, whereas mobile or protruding material has greater embolic potential. Contrast echocardiography and CMR with dedicated sequences increase sensitivity. Apical thrombus requires anticoagulation and follow-up imaging together with assessment for possible systemic emboli.

Scar creates areas of slow conduction around nonviable tissue, generating monomorphic reentrant ventricular tachycardia. Unlike sudden ventricular fibrillation, these circuits may produce recurrent episodes and ICD shocks. Endocardial mapping may not reach an epicardial or intramural substrate. The aneurysmal border therefore becomes a potential ablation target in expert centers.

Apical pressure and ischemia may contribute to dilation, but not all aneurysms progress at the same rate. Size, thrombus, symptoms and arrhythmias are compared serially using the same imaging modality. A millimetric difference between techniques does not demonstrate growth. Morphologic monitoring should use reproducible planes and also describe the residual cavity and midventricular gradient.

The left atrium may dilate because of diastolic dysfunction even without obstruction. Fibrillation and pulmonary pressure contribute to dyspnea and embolic risk independently of the aneurysm. A patient may therefore simultaneously have atrial and ventricular sources of thromboembolism. Thrombotic assessment should not stop after a single abnormality has been found.

Prolonged apical obliteration may trap a small amount of blood until diastole. Late emptying flow may be observed by Doppler and suggests a functionally separated cavity, but by itself does not equal an aneurysm. Intracavitary dynamics should be correlated with the wall, scar and midventricular gradient to avoid overinterpretation.

Basal mechanics may compensate for reduced apical function for a long time, maintaining global ejection fraction. Regional strain and volumes show this redistribution before overt deterioration. Basal compensation explains why a ventricle with substantial distal scar may appear hyperdynamic and makes the global value alone inadequate.

Electrocardiogram and multimodality imaging

The classic ECG shows deep, symmetric T-wave inversions in the precordial and sometimes inferior leads, with high voltages. Depth may vary over time and does not correlate perfectly with thickness; confirmed forms may have modest abnormalities. Ischemia, cardiac memory and other cardiomyopathies produce similar patterns. Giant T waves are a useful diagnostic signal, not a sufficient criterion.

Echocardiography should avoid foreshortening by acquiring the apex as distally as possible and comparing multiple windows. The endocardial border is followed in diastole and systole to distinguish wall, trabeculations and papillary muscles. Contrast is indicated when two or more segments are not visible or obliteration, aneurysm or thrombus is suspected. Apical image quality should be declared in the report rather than concluding normality from inadequate images.

The spade-shaped cavity results from progressive reduction of the lumen toward the apex. This appearance may be evident on ventriculography, contrast echocardiography or cine CMR, but is not present in every form. The wall-thickness ratio and length of the involved segment complete the description. Diastolic geometry distinguishes a truly hypertrophied apex from a cavity merely foreshortened during acquisition.

Doppler searches for a midventricular gradient and paradoxical diastolic flow from the apical chamber toward the base. An intracavitary systolic signal may be confused with regurgitation or LVOTO if the sample position is not tracked with color Doppler. Absence of a gradient does not exclude high apical pressures, especially with near-complete obliteration. Hemodynamic localization requires scanning from the apex to the outflow tract.

Cardiac magnetic resonance is the reference for complex morphology. Cine images identify hypertrophy, obliteration and aneurysm; LGE defines scar; T1 and ECV support the differential diagnosis. The two-chamber view and distal short-axis sections prevent the apex from being skipped. CMR is particularly indicated when ECG and symptoms suggest ApHCM despite negative echocardiography.

A small aneurysm may be visible only on high-resolution cine imaging or after contrast. Thrombus appears as a mass without perfusion or enhancement, but dedicated inversion times may be necessary. Distinction from trabeculations, tumor or artifact requires multiple sequences. Thrombus imaging should be repeated after anticoagulation to document response and residual material.

Cardiac CT provides good anatomic resolution when CMR is contraindicated and can assess coronary arteries and the apex in the same examination. It does, however, expose the patient to radiation and iodinated contrast and characterizes tissue less completely. Invasive ventriculography now has a limited role but may reveal the spade-shaped cavity or aneurysm during coronary angiography. The choice of modality depends on the question rather than on an absolute hierarchy.

ECG monitoring and exercise testing complement imaging. NSVT, sustained arrhythmias, blood pressure response and capacity modify risk and management; exercise may also reveal an associated gradient not visible at rest. Cardiopulmonary testing quantifies a limitation that morphology does not predict accurately. Integrated phenotyping links apical anatomy, scar, rhythm and performance.

Serial ECGs may show progressively deeper T-wave negativity or, conversely, attenuation as the apex thins. Apparent normalization does not prove improvement and may accompany adverse remodeling. Electrical change gains meaning only together with CMR, volumes and symptoms.

Stress perfusion by CMR or nuclear techniques may demonstrate microvascular defects but is not required in every patient. It is selected when pain and coronary risk require distinction or when the result changes therapy. Ischemia imaging does not replace anatomic coronary assessment in people with a significant probability of epicardial disease.

Clinical manifestations, risk and prognosis

Many diagnoses are incidental after an abnormal ECG, whereas the most common symptoms are pain, dyspnea, palpitations and fatigue. Pain may reflect microvascular ischemia and does not require epicardial stenosis, but coronary probability must be respected. Dyspnea results from stiffness, a reduced cavity, fibrillation or a midventricular gradient. The dominant mechanism is defined before selecting medications.

Atrial fibrillation is an important cause of deterioration and thromboembolism. The apical form does not protect against atrial dilation or increased pressures. Clinical episodes require anticoagulation irrespective of CHA2DS2-VASc, unless contraindicated, and a rhythm strategy may improve tolerance. Atrial embolic risk adds to that of any aneurysm.

Risk of sudden death is assessed with markers used for HCM as a whole, but apical aneurysm is a major risk factor in the American approach and may not be fully represented by calculators. LGE, NSVT, syncope, family history, wall thickness and function complete the assessment. An apical form without aneurysm is not automatically at zero risk. The ICD decision requires absolute values, age and anticipated device complications.

Monomorphic tachycardias are particularly associated with aneurysmal scar. They may be slow and fall below therapy zones set too high, or rapid and cause syncope. ICD programming, antiarrhythmic drugs and ablation are coordinated to reduce shocks. Ventricular arrhythmic burden is not summarized by the presence or absence of a single NSVT episode on brief monitoring.

Thromboembolic risk with an aneurysm depends on stasis, size and documented thrombus. When thrombus is present, anticoagulation is indicated; without thrombus or fibrillation, evidence for universal prophylaxis is insufficient and the choice is individualized. Bleeding and feasibility of surveillance enter the balance. The anticoagulation decision should distinguish an established recommendation from a precautionary strategy based on observational data.

Heart failure may occur with preserved ejection fraction or progress to dysfunction. An obliterated apical cavity reduces stroke volume and may cause severe limitation without dilation; aneurysm and scar may instead accompany remodeling. Natriuretic peptides and cardiopulmonary testing help define severity. Functional progression requires serial comparison and cannot be inferred from wall thickness alone.

Historical cohorts reported favorable survival but often included few aneurysms and used different criteria. Contemporary studies show that average risk often remains lower than in other phenotypes while events concentrate in subgroups. A recently proposed specific score requires external validation before universal use. Individual prognosis should be based on established markers rather than on the traditional reputation of the form.

Fabry disease may mimic ApHCM and has distinct prognostic and therapeutic implications. An apical ischemic scar, endomyocardial disease or a mass also completely changes risk. Differential diagnosis is not merely an initial step because new extracardiac signs may emerge over time. Etiologic reassessment is justified when the course does not match what is expected.

Syncope should be analyzed according to context, prodromes and rhythm. An aneurysm increases concern for a ventricular cause, but vasovagal episodes remain common. Prolonged monitoring may be more useful than repeated untargeted tests. Arrhythmic syncope is not diagnosed by morphologic association but after an assessment excluding more plausible explanations.

The prognosis of small aneurysms is less well defined than that of large symptomatic forms. Small size does not eliminate the scar substrate, but absolute risk may be lower and must be balanced against ICD complications. Size-based stratification remains imperfect and requires shared decision-making based on the entire profile.

Treatment, complications and follow-up

An asymptomatic patient without relevant markers is followed without treatment intended to reduce wall thickness. Blood pressure, weight, sleep apnea and coronary risk are controlled and physical activity is prescribed individually. Surveillance includes ECG, echocardiography and rhythm assessment, with CMR when it can change management. Apical follow-up should specifically assess obliteration, scar, aneurysm and thrombus.

Beta-blockers or nondihydropyridine calcium-channel blockers may relieve palpitations, pain or dyspnea by slowing heart rate and favoring filling, but specific evidence is limited. Cautious diuretics treat congestion without excessively reducing volume. Nitrates and vasodilators require caution if a midventricular or outflow gradient is present. Symptomatic response should be verified and ineffective medications should not be continued by inertia.

Myosin inhibitors are approved for symptomatic obstructive disease, not for apical location alone when nonobstructive. An apical patient with LVOTO may be eligible according to general indications, but aneurysm or a midventricular gradient are not automatically equivalent targets. Pharmacologic selection depends on documented hemodynamics and the population studied in trials.

Apical myectomy is a specialist procedure for selected patients with a very small cavity, low output and refractory symptoms. Through a transapical approach, resection increases volume and may improve filling and capacity; risks include septal defect, bleeding, aneurysm and arrhythmias. It is not indicated merely because hypertrophy is present. Apical surgery requires detailed imaging and a center with specific expertise.

An aneurysm with recurrent tachycardia may require an ICD, antiarrhythmic drugs and endocardial or combined ablation according to the circuit. Aneurysm resection is considered rarely, often together with surgery required for midventricular obstruction or thrombus. Benefit must be weighed against the risk of ventriculotomy. The arrhythmia strategy is multimodal and does not assume that eliminating one circuit removes future risk.

Thrombus is anticoagulated and followed by imaging until resolution, with continuation according to aneurysm characteristics and risk. An embolic event requires investigation for residual thrombus, fibrillation and other sources. Drug choice considers evidence, kidney function, interactions and adherence. Thrombotic surveillance should continue if a dyskinetic cavity persists because thrombus resolution does not normalize flow.

The family follows the same genetic pathway used for HCM without expecting apical distribution to recur identically. A relative may show septal or relative disease, or no phenotype, despite carrying the same variant. An ECG with abnormal T waves may precede hypertrophy and prompt CMR. Intrafamilial variability prevents limiting screening to the search for an already markedly thickened apex.

Quality of care depends on recognizing a form that echocardiography can miss and complications that the historically benign label may minimize. Once the phenotype is defined, treatment remains proportionate: many patients require surveillance alone, whereas aneurysm, thrombus, arrhythmias or severe limitation require specialist interventions. Diagnostic precision avoids both excessive reassurance and unjustified procedures.

Pregnancy in a stable woman is often tolerated, but aneurysm, arrhythmias, dysfunction or anticoagulation require a specialist plan. Rapid postpartum volume shifts may precipitate congestion. Preconception assessment also addresses inheritance and medications without assuming that apical location makes risk negligible.

Noncardiac surgery and anesthesia require knowledge of cavity size, gradient and arrhythmias. Hypotension and tachycardia may reduce output, whereas excessive volume expansion promotes congestion. Perioperative management is adapted to current physiology and not to the mere presence of the word apical in the report.